Skip to main content

Ad Scientiam strengthens its collaboration with patient advocacy groups!

Driven by the wish to develop relevant and useful mobile applications, Ad Scientiam closely collaborates with patient advocacy groups at every step of its digital solution development process.

DAMS is a monitoring and self-assessment smartphone application for patients with multiple sclerosis.

Starting in summer 2016, interviews of patients recruited by the ARSEP were organized as part of DAMS development.

Ad Scientiam organizes a day of user tests with patient advocacy groups at least once every quarter. In 2017, several dozens of patients were able to get started with DAMS and actively participated to its conception. These tests aim at validating and/or improving DAMS usability and reliability.

We warmly thank Canne à SEP in Luneville, the AFSEP and the APF in Melun et Elan SEP in Elancourt with the Ligue contre la Sclérose en Plaques for their kindness and availability.


ARSEP website

Canne à SEP Facebook page

AFSEP website

APF website

Ligue contre la Sclérose en Plaques website - Elan SEP contact details

Latest News

Ad Scientiam solution, MSCopilot (Digital self-Assessment for Multiple Sclerosis), was...

Driven by the wish to develop relevant and useful mobile applications, Ad Scientiam closely collaborates with patient advocacy groups at every step of...

Ad Scientiam launches its own validation clinical study on 200 patients in 10 Neurology centers specialized in Multiple Sclerosis

An article about Ad Scientiam and how new information and communication technologies impact healthcare. In French

Despite the innovation that could bring ResearchKit to clinical research, its use in France is currently limited. Indeed, legislation about clinical...

Ad Scientiam collaborates with researchers to improve our understanding about Attention Deficit Disorder with or without Hyperactivity.

Ad Scientiam collaborates with Dr. Mehran Firouzeh in a draft CEBT

Ad scientiam teams up with young researchers by supporting them during their study and by allowing them to have an access to its application.

Last april, Apple just launched a new promising tool for medical research : ResearchKit. This software is an open source framework which include...

The BRAiN’US project was born at the Brain and Spine Institute. The goal of the project is to gather information on how the brain really works.

Symptoms and side effects can be collected in real time from patients through their smartphone.


Ad Scientiam Research allows collecting data relative to asthma symptoms as often as required using the notification tool.


Ad Scientiam also contributes to sleep research by allowing data gathering in order to better understand our sleeping patterns.

Inclusion in cohorts

Ad Scientiam Research allows exploring small changes in environments and patient symptoms.


Ad Scientiam constructs tools for epidemiological studies regarding exercises / physical activities performed by obese patients.

Ad Scientiam is also concerned by the health of younger patients and has set as one of its objectives to promote sport and balanced diet.

In collaboration with a cardiology department and an engineering school, Ad Scientiam is developing an electronic aftercare telemonitoring solution...

Alcohol dependency

Patients can type in data concerning their alcohol usage and benefit from personalised help and follow up on their progress.

Patient compliance

Ad Scientiam is developing a solution allowing increasing patient answering rate as it coaches patients to improve answer rates to questions.

Parkinson's disease

Ad Scientiam contributes to research by gathering and analyzing data on Parkinson's symptom changes.

Addiction medicine

Understand and quantify the cannabis use on patient is an important step for addiction specialists.

Understanding Real World Data history